20 October 2022
Pirbright to join efforts in mpox research as part of new consortium
The Pirbright Institute is taking a lead role in a new mpox consortium. The group will work together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness and the virus’ spread. The mpox Consortium has received £2million investment from the Biotechnology…
Read more
